Friday, July 10, 2026

pharma · HIV Infections · HIV-1 infection

ViiV Healthcare Pty

ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, HIV-1 infection, Human immunodeficiency virus (HIV), human immunodeficiency virus (HIV). NovaP

London, GB HQ
2009 Founded
1,906 Employees
TGA registrant Type
Company details
Status
Public
HQ
London, GB
Founded
2009
Employees
1,906
Programs
10
Drugs
27
Patents
0
Clinical program

219700

Phase 3 · small molecule · HIV-1 infection

219700 for HIV-1 infection is a Phase 3 program (small_molecule) at ViiV Healthcare Pty Ltd with 1 ClinicalTrials.gov record(s).

← All ViiV Healthcare Pty Ltd projects Phase 3 small molecule active

Internal code 219700

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ViiV Healthcare Pty Ltd
Phase
Phase 3
Modality
small_molecule
Indication
HIV-1 infection
Status
active
Trials
1